Dry eye is an extremely common condition that is often under diagnosed and affects 5-30% of the population aged 50 years and older.

The InflammaDry™ test identifies patients with elevated levels of matrix metalloproteinase (MMP-9), a clinically relevant marker for chronic dry eye. By implementing InflammaDry™ into your practice, you can:
  • Make a rapid, accurate diagnosis before the patient leaves your office
  • Reduce complications associated with dry eye
  • Help improve clinical and surgical outcomes
  • Create a safer and better patient experience